Latest Breaking News On - Equity incentive plan - Page 15 : comparemela.com

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

South san franciscoUnited statesSan diegoDominic piscitelliCompensation committee of the board directorsPharmaceuticals incSecurities exchangeExchange commissionReports inducement grantsNasdaq listing ruleEquity incentive planGrant dateEquity incentiveNasdaq ruleSecurities actSecurities exchange act

Form PRE 14A Vistagen Therapeutics, For: May 29

Form PRE 14A Vistagen Therapeutics, For: May 29
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPalo altoNew yorkNew canaanSan franciscoSouth san franciscoChen yuJerroldd dotsonShawnk singhMichelle rossMargaretm fitzpatrickReidg adlerMargaret fitzpatrickRobert egenCynthia andersonMaryl rotunno

Form DEF 14A SmartRent, Inc For: May 14

Form DEF 14A SmartRent, Inc For: May 14
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkMarshall schoolTejon ranchUniversity of arizonaOccidental collegeGrand canyon universityRocky mountainHiroshi okamotoBruce strohmIsaiah derose wilsonWaller lansden dortch davisAnn sperlingSnell wilmerSemler brossyFrederick tuomi

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases.

United statesLifesci communicationsPharmaceuticals incCompensation committee of the board directorsPharmaceuticals nasdaqEquity incentive planNasdaq listing rule

Pivotree Strengthens Executive Team with Appointment of Kyle Metcalf to Chief Revenue Officer

Pivotree Inc. , a leading provider of frictionless commerce solutions and services, today announced the appointment of Kyle Metcalf as Chief Revenue Officer, effective April 1st, 2024. In his role.

Kyle metcalfCompany equity incentive plan theZiff davisPivotree incRegulation services providerVenture exchangeChief revenue officerBill di nardoLiving securityEquity incentive planManagement information circularData managementSupply chain